| Literature DB >> 9342016 |
T Lövgren1, P Heinonen, P Lehtinen, H Hakala, J Heinola, R Harju, H Takalo, V M Mukkala, R Schmid, H Lönnberg, K Pettersson, A Iitiä.
Abstract
Future immunoassays and nucleic acid hybridization assays will be performed in miniaturized formats that utilize microchips or microparticles. This will require a sensitive detection technology that allows spatial resolution. By using fluorescent europium chelates and time-resolved microfluorometry, one can detect 11,000 europium molecules on individual microparticles. In a miniaturized noncompetitive immunoassay of prostate-specific antigen (PSA), we quantitatively detected 5 ng/L (0.05 amol per particle) of the analyte on an individual microparticle with excellent precision over the whole measurement range (CV <10%). Using a hybridization assay, we also could detect the deltaF508 mutation for cystic fibrosis on individual microparticles. Consequently, fluorescent lanthanide chelate labels and time-resolved microfluorometry qualify as the next generation of technology in this field.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9342016
Source DB: PubMed Journal: Clin Chem ISSN: 0009-9147 Impact factor: 8.327